|

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

RECRUITINGN/ASponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
PhaseN/A
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2025-10-24
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The psychological challenges faced by patients with incurable cancer and their caregivers include an uncertain future, fear of dying and uncontrollable suffering, grief, and loneliness. In a significant subgroup, this challenge is associated with significant fear and existential distress. This distress can manifest itself, for example, in the form of demoralization, a state of despair and hopelessness in which the possibilities for coping seem exhausted. Although open discussions about fears at the end of life are becoming increasingly important, little is known about how patients with high existential distress can best be supported to promote quality of life. The aim of the study is to test the effectiveness of the newly developed individual psychotherapy ORPHYS (ShORt-term psychodynamic psychotherapy in serious PHYSical illness) in reducing existential distress. To this end, a randomly selected half of the participants who receive ORPHYS treatment will be compared with a second group who receive the standard routine psycho-oncological treatment TAU (Treatment As Usual). The level of distress caused by demoralization will be used for the comparison. A total of 160 patients with advanced cancer will be included in the study. Due to improved treatment options, life expectancy for advanced cancer has increased significantly. This means that patients and their families must deal with the existential tension between uncertainty and a focus on life. The treatment is intended to contribute to providing the best possible support for patients who suffer from uncertainty and fears at the end of life.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* UICC stage III/IV solid tumor or advanced hematological cancer
* Physical condition at beginning of treatment sufficient for outpatient treatment
* Existential distress due to at least one of the following concerns: loss of hope, demoralization, fear of the future, loneliness, death anxiety, sense of isolation, death wishes
* Severity of distress: significant subjective distress and impairment in functioning

Exclusion Criteria:

* Acute suicidality with concrete or impending intent to follow through (suicide plan)
* diagnosis of a substance dependence, substance abuse, or psychotic disorder (exception: tobacco-related disorders)
* Inability to adhere to a psychotherapeutic setting
* Other current psychotherapeutic or psycho-oncological treatment according to TAU definition
* Insufficient German to give informed consent and complete self-report questionnaires

Conditions2

Advanced Cancer, Various, NOSCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.